| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.52 Billion | USD 11.38 Billion | 7.50% | 2024 |
FrequentlyAsked Questions
Breast cancer detection refers to tools and methods used for the diagnosis of breast cancer, either in earlier stages or after the symptoms appear.
The global breast cancer detection market is expected to be driven by the rising prevalence of breast cancer across the globe.
According to study, the global breast cancer detection market size was worth around USD 5.52 billion in 2024 and is predicted to grow to around USD 11.38 billion by 2034.
The CAGR value of the breast cancer detection market is expected to be around 7.50% during 2025-2034.
The global breast cancer detection market is expected to be led by North America during the projection period.
The global breast cancer detection market is led by players like Canon Medical Systems, GE Healthcare, Philips Healthcare, ScreenPoint Medical, iBreastExam (UE LifeSciences), Natera, Inc., Siemens Healthineers, Niramai Health Analytix, Roche Diagnostics, Hologic, Inc., iSono Health, Guardant Health, Fujifilm Holdings Corporation, Braster S.A., and iCAD Inc.
The report explores crucial aspects of the breast cancer detection market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients